299 related articles for article (PubMed ID: 28973635)
1. Liver-directed gene therapy for murine glycogen storage disease type Ib.
Kwon JH; Lee YM; Cho JH; Kim GY; Anduaga J; Starost MF; Mansfield BC; Chou JY
Hum Mol Genet; 2017 Nov; 26(22):4395-4405. PubMed ID: 28973635
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
[TBL] [Abstract][Full Text] [Related]
3. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
Kim GY; Lee YM; Kwon JH; Cho JH; Pan CJ; Starost MF; Mansfield BC; Chou JY
Mol Genet Metab; 2017 Mar; 120(3):229-234. PubMed ID: 28096054
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology and gene therapy for glycogen storage disease type Ib.
Chou JY; Cho JH; Kim GY; Mansfield BC
J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
[TBL] [Abstract][Full Text] [Related]
5. Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.
Yiu WH; Pan CJ; Mead PA; Starost MF; Mansfield BC; Chou JY
J Hepatol; 2009 Nov; 51(5):909-17. PubMed ID: 19376605
[TBL] [Abstract][Full Text] [Related]
6. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Chou JY; Jun HS; Mansfield BC
J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
[TBL] [Abstract][Full Text] [Related]
7. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
Chen LY; Pan CJ; Shieh JJ; Chou JY
Hum Mol Genet; 2002 Dec; 11(25):3199-207. PubMed ID: 12444104
[TBL] [Abstract][Full Text] [Related]
8. Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.
Yiu WH; Pan CJ; Allamarvdasht M; Kim SY; Chou JY
Gene Ther; 2007 Feb; 14(3):219-26. PubMed ID: 17006547
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage.
Cho JH; Lee YM; Starost MF; Mansfield BC; Chou JY
J Inherit Metab Dis; 2019 May; 42(3):459-469. PubMed ID: 30637773
[TBL] [Abstract][Full Text] [Related]
10. The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia.
Lee YM; Pan CJ; Koeberl DD; Mansfield BC; Chou JY
Mol Genet Metab; 2013 Nov; 110(3):275-80. PubMed ID: 23856420
[TBL] [Abstract][Full Text] [Related]
11. Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.
Kim GY; Lee YM; Cho JH; Pan CJ; Jun HS; Springer DA; Mansfield BC; Chou JY
Hum Mol Genet; 2015 Sep; 24(18):5115-25. PubMed ID: 26089201
[TBL] [Abstract][Full Text] [Related]
12. Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia.
Lee YM; Kim GY; Pan CJ; Mansfield BC; Chou JY
Mol Genet Metab Rep; 2015 Jun; 3():28-32. PubMed ID: 26937391
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia.
Zhang L; Lee C; Arnaoutova I; Anduaga J; Starost MF; Mansfield BC; Chou JY
Biochem Biophys Res Commun; 2020 Jun; 527(3):824-830. PubMed ID: 32430177
[TBL] [Abstract][Full Text] [Related]
14. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
Chen SY; Pan CJ; Nandigama K; Mansfield BC; Ambudkar SV; Chou JY
FASEB J; 2008 Jul; 22(7):2206-13. PubMed ID: 18337460
[TBL] [Abstract][Full Text] [Related]
15. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.
Chou JY; Jun HS; Mansfield BC
Nat Rev Endocrinol; 2010 Dec; 6(12):676-88. PubMed ID: 20975743
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for type I glycogen storage diseases.
Chou JY; Mansfield BC
Curr Gene Ther; 2007 Apr; 7(2):79-88. PubMed ID: 17430128
[TBL] [Abstract][Full Text] [Related]
17. An evolutionary approach to optimizing glucose-6-phosphatase-α enzymatic activity for gene therapy of glycogen storage disease type Ia.
Zhang L; Cho JH; Arnaoutova I; Mansfield BC; Chou JY
J Inherit Metab Dis; 2019 May; 42(3):470-479. PubMed ID: 30714174
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of an inducible mouse model for glycogen storage disease type Ib.
Raggi F; Pissavino AL; Resaz R; Segalerba D; Puglisi A; Vanni C; Antonini F; Del Zotto G; Gamberucci A; Marcolongo P; Bosco MC; Grillo F; Mastracci L; Eva A
J Inherit Metab Dis; 2018 Nov; 41(6):1015-1025. PubMed ID: 29967951
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.
Chen LY; Shieh JJ; Lin B; Pan CJ; Gao JL; Murphy PM; Roe TF; Moses S; Ward JM; Lee EJ; Westphal H; Mansfield BC; Chou JY
Hum Mol Genet; 2003 Oct; 12(19):2547-58. PubMed ID: 12925567
[TBL] [Abstract][Full Text] [Related]
20. New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
Soty M; Chilloux J; Casteras S; Grichine A; Mithieux G; Gautier-Stein A
Biochimie; 2012 Mar; 94(3):695-703. PubMed ID: 21983240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]